TY - JOUR
T1 - Cardiac Arrest during Long-Distance Running Races
AU - Kim, Jonathan H.
AU - Rim, Austin J.
AU - Miller, James T.
AU - Jackson, Mekensie
AU - Patel, Neeya
AU - Rajesh, Sanchitha
AU - Ko, Yi An
AU - Digregorio, Heather
AU - Chiampas, George
AU - McGillivray, David
AU - Holder, Jay
AU - Baggish, Aaron L.
N1 - Publisher Copyright:
© 2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.
PY - 2025/5/20
Y1 - 2025/5/20
N2 - Importance: More than 29 million participants completed marathons and half-marathons in the US between 2010-2023, approximately 3 times the number from 2000-2009. Contemporary long-distance race-related cardiac arrest incidence and outcomes are unknown. Objective: To determine the incidence and outcomes of cardiac arrests during US marathons and half-marathons between 2010-2023 from a record of race finishers and a comprehensive review of cases from media reports, direct contact with race directors, USA Track & Field claims, and interviews with survivors or next of kin. Design, Setting, and Participants: Observational case series from the Race Associated Cardiac Event Registry; cohort data from US marathon and half-marathon runners from January 1, 2010, to December 31, 2023. Case profiles were reviewed to determine etiology and factors associated with survival. Incidence and etiology data were compared with historical reference standards (2000-2009). Exposure: Recreational long-distance running (marathon and half-marathon distance). Main Outcomes: Incidence proportions of sudden cardiac arrest and death. Results: Among 29311597 race finishers, 176 cardiac arrests (127 men, 19 women, 30 sex unknown) occurred during US long-distance running races. Compared with 2000-2009, cardiac arrest incidence remained unchanged (incidence rate, 0.54 per 100000 participants [95% CI, 0.41-0.70] vs 0.60 per 100000 [95% CI, 0.52-0.70], respectively). However, there were significant declines in cardiac death incidence (0.20 per 100000 [95% CI, 0.15-0.26] vs 0.39 per 100000 [95% CI, 0.28-0.52]) and case fatality rate (34% vs 71%). Cardiac arrests remained more common among men (1.12 per 100000 [95% CI, 0.95-1.32]) than women (0.19 per 100000 [95% CI, 0.13-0.27]) and during the marathon (1.04 per 100000 [95% CI, 0.82-1.32]), compared with the half-marathon (0.47 per 100000 [95% CI, 0.38-0.57]). Among runners for which a definitive cause of cardiac arrest could be determined (n = 67/128 [52%]), coronary artery disease rather than hypertrophic cardiomyopathy was the most common etiology. Decreased cardiopulmonary resuscitation time and an initial ventricular tachyarrhythmia rhythm were associated with survival. Conclusions and Relevance: Despite increased participation in US long distance running races, cardiac arrest incidence remains stable. There has been a marked decline in cardiac arrest mortality, and coronary artery disease was the most common etiology among cases with sufficient cause-related data. Effective emergency action planning with immediate access to defibrillation may explain the improvement in survival.
AB - Importance: More than 29 million participants completed marathons and half-marathons in the US between 2010-2023, approximately 3 times the number from 2000-2009. Contemporary long-distance race-related cardiac arrest incidence and outcomes are unknown. Objective: To determine the incidence and outcomes of cardiac arrests during US marathons and half-marathons between 2010-2023 from a record of race finishers and a comprehensive review of cases from media reports, direct contact with race directors, USA Track & Field claims, and interviews with survivors or next of kin. Design, Setting, and Participants: Observational case series from the Race Associated Cardiac Event Registry; cohort data from US marathon and half-marathon runners from January 1, 2010, to December 31, 2023. Case profiles were reviewed to determine etiology and factors associated with survival. Incidence and etiology data were compared with historical reference standards (2000-2009). Exposure: Recreational long-distance running (marathon and half-marathon distance). Main Outcomes: Incidence proportions of sudden cardiac arrest and death. Results: Among 29311597 race finishers, 176 cardiac arrests (127 men, 19 women, 30 sex unknown) occurred during US long-distance running races. Compared with 2000-2009, cardiac arrest incidence remained unchanged (incidence rate, 0.54 per 100000 participants [95% CI, 0.41-0.70] vs 0.60 per 100000 [95% CI, 0.52-0.70], respectively). However, there were significant declines in cardiac death incidence (0.20 per 100000 [95% CI, 0.15-0.26] vs 0.39 per 100000 [95% CI, 0.28-0.52]) and case fatality rate (34% vs 71%). Cardiac arrests remained more common among men (1.12 per 100000 [95% CI, 0.95-1.32]) than women (0.19 per 100000 [95% CI, 0.13-0.27]) and during the marathon (1.04 per 100000 [95% CI, 0.82-1.32]), compared with the half-marathon (0.47 per 100000 [95% CI, 0.38-0.57]). Among runners for which a definitive cause of cardiac arrest could be determined (n = 67/128 [52%]), coronary artery disease rather than hypertrophic cardiomyopathy was the most common etiology. Decreased cardiopulmonary resuscitation time and an initial ventricular tachyarrhythmia rhythm were associated with survival. Conclusions and Relevance: Despite increased participation in US long distance running races, cardiac arrest incidence remains stable. There has been a marked decline in cardiac arrest mortality, and coronary artery disease was the most common etiology among cases with sufficient cause-related data. Effective emergency action planning with immediate access to defibrillation may explain the improvement in survival.
UR - http://www.scopus.com/inward/record.url?scp=105003057990&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105003057990&partnerID=8YFLogxK
U2 - 10.1001/jama.2025.3026
DO - 10.1001/jama.2025.3026
M3 - Article
C2 - 40159341
AN - SCOPUS:105003057990
SN - 0098-7484
VL - 333
SP - 1699
EP - 1707
JO - JAMA
JF - JAMA
IS - 19
ER -